Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Actas Esp Psiquiatr ; 52(3): 375-377, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38863053

ABSTRACT

A case of Kloos syndrome is presented, a rare psychopathological manifestation in psychiatry characterized by the experience of "time paralysis" related to an epileptic focus in the left temporoparietal areas. This syndrome was identified through a detailed psychopathological analysis and detected by an electroencephalographic record. The patient's symptoms disappeared after receiving antiepileptic treatment with Carbamazepine. In this case report we highlight the detailed phenomenological and clinical analysis, as well as the importance of carrying out complementary tests when we are faced with unusual or sudden-onset symptoms without any trigger, as took place in the case exposed.


Subject(s)
Electroencephalography , Humans , Syndrome , Male , Carbamazepine/therapeutic use , Adult , Anticonvulsants/therapeutic use
2.
Rev. esp. drogodepend ; 46(1): 21-41, 2021. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-232064

ABSTRACT

Introducción: Existe una elevada comorbilidad entre el trastorno por déficit de atención e hiperactividad (TDAH) y el trastorno por consumo de sustancias, asociando una mayor gravedad de las adicciones, menor edad de inicio del consumo, así como una mayor cronicidad de la drogodependencia. En los pacientes con patología dual el tratamiento resulta ser una tarea compleja, por lo que la eficacia farmacológica ha sido objeto de múltiples estudios académicos en las últimas décadas. Objetivos: El objetivo principal es realizar una revisión bibliográfica acerca de esta comorbilidad, para conocer si el TDAH se considera un factor de riesgo en el desarrollo de un Trastorno por Consumo de Sustancias (TCS) en la adolescencia y en la edad adulta. También se pretende examinar si el tratamiento farmacológico del TDAH previene el desarrollo de TCS y si es segura su prescripción en pacientes con dicha comorbilidad. Metodología: Se realizó una búsqueda bibliográfica principalmente en la base de datos PubMed, en la que se introdujeron las palabras clave y se aplicaron los criterios de inclusión y de exclusión. Resultados: Los pacientes con TDAH tienen más riesgo de desarrollar dependencia al alcohol (OR 2,31), a la nicotina (OR 2,28) y al cannabis (OR 1,73); así como de desarrollar un TCS (OR 2,49) en la edad adulta. Conclusiones: El TDAH es un factor de riesgo para padecer un TCS, siendo seguro el tratamiento en pacientes con patología dual además de mejorar la drogodependencia. (AU)


Introduction: There is a high comorbidity between attention deficit hyperactivity disorder (ADHD) and substance use disorder, with a higher severity of addictions, an earlier age on the onset of the consumption, as well as an increased chronic drug dependence. In patients with dual pathology treatment appears to be a complex task, causing the pharmacological efficacy to be object of study of multiple academic studies in the recent decades. Objectives: The main objective is to carry out a literature review on this comorbidity, in order to know if ADHD is considered a risk factor in the development of a Substance use disorders (SUD) in adolescence and adulthood. It is also intended to analyze whether the pharmacological treatment of ADHD prevents from the development of SUD and whether its prescription is safe in patients with such comorbidity. Methodology: A bibliographic research was carried out mainly in the PubMed database, in which the keywords were introduced, and the inclusion and exclusion criteria applied. Results: Patients with ADHD are at greater risk of developing dependence on alcohol (OR 2.31), nicotine (OR 2.28) and cannabis (OR 1.73); and developing a substance abuse disorder (SUD) (OR 2.49) in adulthood. Conclusions: Attention deficit hyperactivity disorder is a risk factor for developing a substance abuse disorder, being the treatment safe in patients with dual pathology as well as improving the drug dependence. (AU)


Subject(s)
Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/drug therapy , Substance-Related Disorders , Comorbidity
SELECTION OF CITATIONS
SEARCH DETAIL
...